{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:57:53Z","timestamp":1787065073324,"version":"build-2736575974"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is currently unknown how post-COVID-19 syndrome (PCS) may affect those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This longitudinal study includes healthcare staff who tested positive for SARS-CoV-2 between March and April 2020, with follow-up of their antibody titers and symptoms. More than half (21 of 38) had PCS after 7\u20138 months. There was no statistically significant difference between initial reverse-transcription polymerase chain reaction titers or serial antibody levels between those who did and those who did not develop PCS. This study highlights the relative commonality of PCS in healthcare workers and this should be considered in vaccination scheduling and workforce planning to allow adequate frontline staffing numbers.<\/jats:p>","DOI":"10.1093\/infdis\/jiab120","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T15:10:42Z","timestamp":1614352242000},"page":"1671-1676","source":"Crossref","is-referenced-by-count":33,"title":["The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post\u2013COVID-19 Syndrome in Healthcare Workers"],"prefix":"10.1093","volume":"223","author":[{"given":"Christopher","family":"Pereira","sequence":"first","affiliation":[{"name":"Cutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London, London, United Kingdom"},{"name":"The Wellington Hospital, Circus Road, St John\u2019s Wood, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H L","family":"Harris","sequence":"additional","affiliation":[{"name":"Computational Biology and Integrative Genomics, Department of Oncology, University of Oxford, Oxford, United Kingdom"},{"name":"The Wellington Hospital, Circus Road, St John\u2019s Wood, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Di Giovannantonio","sequence":"additional","affiliation":[{"name":"Computational Biology and Integrative Genomics, Department of Oncology, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Rosadas","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte-Eve","family":"Short","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Quinlan","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maci\u00e0","family":"Sureda-Vives","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Day-Weber","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Marchesin","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia","family":"Katsanovskaja","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Tedder","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra O","family":"McClure","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Dani","sequence":"additional","affiliation":[{"name":"Cutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London, London, United Kingdom"},{"name":"Department of Geriatric Medicine, Hammersmith Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fertleman","sequence":"additional","affiliation":[{"name":"Cutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"2021052811200716200_CIT0001","volume-title":"Coronavirus disease (COVID-19) global epidemiological situation","author":"World Health Organization","year":"2020"},{"key":"2021052811200716200_CIT0002","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"2021052811200716200_CIT0003","doi-asserted-by":"crossref","first-page":"224","DOI":"10.12688\/wellcomeopenres.16307.1","article-title":"Why the patient-made term \u201cLong Covid\u201d is needed","volume":"5","author":"Perego","year":"2020","journal-title":"Wellcome Open Res"},{"key":"2021052811200716200_CIT0004","author":"National Institute for Health and Care Excellence."},{"key":"2021052811200716200_CIT0005","article-title":"Attributes and predictors of long-COVID: analysis of COVID cases and their symptoms 1 collected by the Covid Symptoms Study App. medRxiv [Preprint: not peer reviewed]. 19 December 2020. medRxiv.","author":"Sudre"},{"key":"2021052811200716200_CIT0006","article-title":"\u201cLong Covid\u201d: evidence, recommendations and priority research. 2020; 1 -11. - Written evidence (COV0050). House of Lords Select Committee; 2020","author":"Greenhalgh"},{"key":"2021052811200716200_CIT0007","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","article-title":"Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans","volume":"5","author":"Seow","year":"2020","journal-title":"Nat Microbiol"},{"key":"2021052811200716200_CIT0008","doi-asserted-by":"crossref","article-title":"Neutralizing and binding antibody kinetics of COVID-19 patients during hospital and convalescent phases","author":"Yao","DOI":"10.1101\/2020.07.18.20156810"},{"key":"2021052811200716200_CIT0009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/infdis\/jiaa618","article-title":"Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection","volume":"223","author":"Crawford","year":"2021","journal-title":"J Infect Dis"},{"key":"2021052811200716200_CIT0010","doi-asserted-by":"crossref","article-title":"Antibodies to SARS-CoV-2 are associated with protection against reinfection.","author":"Lumley","DOI":"10.1101\/2020.11.18.20234369"},{"key":"2021052811200716200_CIT0011","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1099\/jgv.0.001439","article-title":"The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection","volume":"101","author":"Kellam","year":"2020","journal-title":"J Gen Virol"},{"key":"2021052811200716200_CIT0012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jiaa610","article-title":"Asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a rehabilitation facility: evolution of the presence of nasopharyngeal SARS-CoV-2 and serological antibody responses","volume":"223","author":"Harris","year":"2021","journal-title":"J Infect Dis"},{"key":"2021052811200716200_CIT0013","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2021052811200716200_CIT0014","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S0140-6736(20)31830-4","article-title":"Testing for responses to the wrong SARS-CoV-2 antigen?","volume":"396","author":"Rosadas","year":"2020","journal-title":"Lancet"},{"key":"2021052811200716200_CIT0015","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/trf.14580","article-title":"Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone","volume":"58","author":"Tedder","year":"2018","journal-title":"Transfusion"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab120\/37494323\/jiab120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/10\/1671\/38360315\/jiab120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/10\/1671\/38360315\/jiab120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:29:47Z","timestamp":1671409787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/10\/1671\/6155862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,3,2]]},"published-print":{"date-parts":[[2021,5,28]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab120","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,15]]},"published":{"date-parts":[[2021,3,2]]}}}